CODX (Co-Diagnostics Corp) Rasio Nilai Pasar marang Nilai Buku

Co-Diagnostics (CODX) - logo korporat

Historical price action for Co-Diagnostics, Inc. (CODX) demonstrates independence from market fluctuations, as the business relies on the production of advanced medical products and the success of clinical tests, with the metric standing at 0.18. Diagnostic reliability is ensured through the implementation of Co-Primers, which eliminate errors in results. Despite an oversupply of offerings in the sector, Co-Diagnostics, Inc. (CODX) maintains its position through patents for AI-based home rapid-test systems.

CODX - Koefisien Nilai Pasar marang Nilai Buku CoDx ing rentang 04.07.2022 - 28.10.2026

Rincian metrik keuangan lan pasar Co-Diagnostics Inc (CODX)

- rega lan prakiraan konsensus rega:
Kutipan saham Co-Diagnostics, Inc.|CODX - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar Co-Diagnostics Corp|CODX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data kapitalisasi buku:
Nilai Buku saben Saham Co-Diagnostics|CODX - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku codiagnostics.com|CODX - Total Aset Bisnis
- data utang lan likuiditas:
Total Utang marang Modal Co-Diagnostics, Inc.|CODX - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Co-Diagnostics Corp|CODX - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Co-Diagnostics Corp
Analisis wiwitan perusahaan:Co-Diagnostics, Inc. - CODX
Barang unggulan Co-Diagnostics Corp

Co-Diagnostics, Inc. (CODX) dominates molecular diagnostics through unique patented methods of ultra-precise PCR analysis. This metric compares the current market value of shares with the issuer's net assets. Investors use this ratio to determine whether the business is overbought or undervalued relative to its tangible asset base. A stable range of values confirms fair market pricing. Analyzing the premium of the market valuation over the book value allows for the identification of hidden risks or growth potential.

Pesaing langsung

Rasio Kapitalisasi marang Aset Bersih Agilent Technologies|DGX (questdiagnostics.com) - Rasio Kapitalisasi marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku ILMN|Rasio Kapitalisasi marang Aset Bersih Exact Sciences Corp|PerkinElmer - Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Bio-Rad Corp (BIO)|NNNN - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku soterahealth.com SHC|QuidelOrtho Corporation - Rasio Kapitalisasi Pasar marang Nilai Buku|OPK: Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku CareDx|Maravai (MRVI) - Rasio Kapitalisasi marang Nilai Buku|FLGT (Fulgent Genetics, Inc.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku LAB|Rasio Nilai Pasar marang Nilai Buku Cytek Biosciences (CTKB)|Rasio Nilai Pasar marang Nilai Buku OraSure Technologies, Inc. OSUR|XGN: Rasio Kapitalisasi marang Aset Bersih|MDxHealth, Inc. - Koefisien Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku LUCD (Lucid Diagnostics Inc.)|PRE - Kapitalisasi Pasar marang Nilai Buku|imdxinc.com - Rasio Kapitalisasi Pasar marang Nilai Buku|TRIB (Trinity Biotech) - Kapitalisasi Pasar marang Nilai Buku|PRPH: Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku Ainos Corporation|Rasio Kapitalisasi Pasar marang Nilai Buku HSCS (Heart Test Laboratories)|Rasio Kapitalisasi marang Aset Bersih BMRA (biomerica.com)|CDIO: Rasio Nilai Pasar marang Nilai Buku|VRAX - Koefisien Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih BJDX|AWH - Rasio Nilai Pasar marang Ekuitas|Rasio Kapitalisasi Pasar marang Nilai Buku Accelerate Diagnostics|CENTOGENE (CNTG) - Rasio Kapitalisasi marang Nilai Buku|ENZ: Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku Fresh2|Rasio Kapitalisasi Pasar marang Nilai Buku GENE|Rasio Kapitalisasi Pasar marang Nilai Buku 23andMe Inc (ME)|PMD (Psychemedics) - Rasio Kapitalisasi Pasar marang Nilai Buku